| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/29/1999 | EP0553107B1 Protein kinase c modulators with anti-inflammatory and antiviral activity |
| 09/29/1999 | CN1230222A PTX-sensitive G proteins, prodn. and use thereof |
| 09/29/1999 | CN1230198A Therapeutic multispecific compounds comprised of anti-FC'alpha' receptor antibodies |
| 09/29/1999 | CN1230197A Subunit respiratory syncytial virus vaccine prepn. |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230194A 3-substituted-d-homo-1,3,5 (10)-estratriene derivatives |
| 09/29/1999 | CN1230188A 25-methylene and 24,25-epoxy marcfortines and paraheroquamides |
| 09/29/1999 | CN1230187A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/29/1999 | CN1230185A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230184A Arylamino fused pyridines and pyrimidines |
| 09/29/1999 | CN1230180A D4 receptor selectivity piperazine derivatives |
| 09/29/1999 | CN1230179A Prepn. of 1-butyl-4-piperidinylmethylamine |
| 09/29/1999 | CN1230178A Polydithiocarbamate-containing macromolecules and use thereof for therapeutic and diagnostic applications |
| 09/29/1999 | CN1230175A Cytostatic hydroxamic acid derivatives |
| 09/29/1999 | CN1230174A Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 09/29/1999 | CN1230173A Substituted N-arylmethylamino derivatives of cyclobutene-3,-4-diones |
| 09/29/1999 | CN1230166A Illudin analogs useful as antitumor agents |
| 09/29/1999 | CN1230165A Cyclopentenones, process for preparing same, and use thereof |
| 09/29/1999 | CN1230123A Inclusion complex containing indole selective serotonin agonist |
| 09/29/1999 | CN1230122A Medical compsns. |
| 09/29/1999 | CN1230121A Means for treating prostate hypertrophy and prostate cancer |
| 09/29/1999 | CN1230119A Methods for enhancing lean tissue mass and bone mineral content and compsns therefor |
| 09/29/1999 | CN1230118A Remedies for hyperphosphatemia |
| 09/29/1999 | CN1230117A Pharmaceutical compsns. with antimicrobial activity |
| 09/29/1999 | CN1230116A Pharmaceutical compsn. for treating viral diseases |
| 09/29/1999 | CN1230115A Use of chelating agent clioquinol for manufacture of pharmaceutical compsn. for treatment of alzheimer's disease |
| 09/29/1999 | CN1230114A Novel treatment of leptine resistance |
| 09/29/1999 | CN1230113A Use of efaroxan for producing medicine for treating huntington disease |
| 09/29/1999 | CN1230112A Method of regulating nicotine metabolism |
| 09/29/1999 | CN1230111A Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 09/29/1999 | CN1230110A Cell adhesion inhibitors |
| 09/29/1999 | CN1229796A Piperazingl cyclohexanols and compositions containing same and use thereof |
| 09/29/1999 | CN1229795A Heterocyclic compounds |
| 09/29/1999 | CN1229669A Extract for treating sore and carbuncle |
| 09/29/1999 | CN1229663A Chinese medicinal prescription for treating liver cancer |
| 09/29/1999 | CN1229652A Compound fish oil |
| 09/29/1999 | CN1229650A Effective rheumatism medicine for arthritis |
| 09/29/1999 | CN1229648A Biological cream and its prepn. method |
| 09/29/1999 | CN1229647A 1,4-diaryl-3-fluoro-2-butene compounds for protecting animals and humans against attach and infestation by arthropod parasites |
| 09/29/1999 | CN1229637A Transparent antidandruff shampoos |
| 09/29/1999 | CN1045295C Process for prepn. of 14,15-dihydro-14-hydroxy-(3,16)-eburnamenine-14-carboxylic acid |
| 09/29/1999 | CN1045294C Method for prepn. of indole derivatives |
| 09/29/1999 | CN1045293C Substituted pyrazoles compounds and medicinal compositions containing same |
| 09/29/1999 | CN1045292C Method for preparing isoascorbic acid |
| 09/29/1999 | CN1045291C Method for prepn. of substituted tetrahydroisoquinolin compound |
| 09/29/1999 | CN1045290C Method for preparation of chelans possesing ortho ligating functionality and complexes |
| 09/28/1999 | US5960337 Method for responding to an emergency event |
| 09/28/1999 | US5959145 12-(methoxy)dodecanoic acid. |
| 09/28/1999 | US5959133 Reacting trans-potassium tetrachloroplatinate and trans-cyclohexanediamine in deoxygenated water in a low oxygen or inert atmosphere |
| 09/28/1999 | US5959127 Acylating sphingosine or sphinganine, hydrolyzing to deblock |
| 09/28/1999 | US5959125 Esterifying a baccatin iii derivative with an acid derivative; antitumor and anticarcinogenic agent |
| 09/28/1999 | US5959113 Reacting a diketone derivative with an aldehyde derivative; administering to treat atherosclerosis, psoriasis, alopecia and tumors |
| 09/28/1999 | US5959110 Substituted tetrahydro-1h-naph(1,2,3-de)isoquinoline compound useful for treating nervous system disorders |
| 09/28/1999 | US5959109 Compounds and methods for increasing endogenous levels of corticotropin-releasing factor |
| 09/28/1999 | US5959107 Inhibitory activity on neuronal cell death (apoptotic cell death-type) caused by excessive apoptosis in a nervous system and they are useful for prevention or treatment of neurodegenerative disorders |
| 09/28/1999 | US5959103 Naphthofluorene compounds, intermediates, compositions, and methods |
| 09/28/1999 | US5959088 Producing fumaric acid salt of erythromycin a derivative by steps of acetylation, hemiketalization, oxidation, alkylation, deacetylation, and decarbonylation; then forming salt and recrystallizing in an alcohol and then ethyl acetate |
| 09/28/1999 | US5959079 CREBA isoform |
| 09/28/1999 | US5959075 Testis-specific insulin homolog polypeptides |
| 09/28/1999 | US5958984 Method and composition for skin treatment |
| 09/28/1999 | US5958983 Novel compounds having antiviral activity against herpes, topical administration them to treat patients with herpes; work by inhibiting the initiation of herpes viral dna synthesis in host cells |
| 09/28/1999 | US5958982 Method for treating patients with sarcoidosis by administering substituted sulfonyl indenyl acetic acids, esters and alcohols |
| 09/28/1999 | US5958980 Treatment of cancer by administering to the mammal in need of treatment 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid or a salt, wherein the effective amount is 50 to 200 mg per day without subjecting said mammal to radiotherapy during the |
| 09/28/1999 | US5958979 Stabilized medicaments containing thyroid hormones |
| 09/28/1999 | US5958978 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 09/28/1999 | US5958976 Composition and method for reducing stinging in skin |
| 09/28/1999 | US5958975 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/28/1999 | US5958974 Diacetyltartaric acid esters of mono- and diglycerides |
| 09/28/1999 | US5958973 Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors |
| 09/28/1999 | US5958971 Chemical compounds |
| 09/28/1999 | US5958969 Osteoporosis |
| 09/28/1999 | US5958968 Cardiovascular disorders; kidney dieases |
| 09/28/1999 | US5958966 Treatment of aberrant cellular states with biomodulators |
| 09/28/1999 | US5958964 Use of melatonin to prevent cytotoxic effects of amyloid beta protein |
| 09/28/1999 | US5958962 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| 09/28/1999 | US5958961 Pharmaceutical composition for angiotensin II-mediated diseases |
| 09/28/1999 | US5958960 Excitatory amino acid receptor modulators |
| 09/28/1999 | US5958959 Administering 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)anilide or 2-cyano-3-hydroxy-n-(4-(trifluoromethyl)phenyl)-2-butenamide |
| 09/28/1999 | US5958958 1,2,4-oxa diazolino and 1,24-oxa diazolidion heterocycles as useful nitric oxide synthase inhibitors |
| 09/28/1999 | US5958956 Aromatic carboxylic acid esters |
| 09/28/1999 | US5958955 Method for the synthesis of a benzimidazole compound |
| 09/28/1999 | US5958954 2,2-dialkyl-4-aryl-substituted benzopyran and benzothiopyran derivatives |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958952 Substituted phenylamindines, medicaments containing these compounds and process for producing them |
| 09/28/1999 | US5958950 Benzimidazole compounds useful for the treatment of inflammatory disease, atherosclerosis, restenosis or inhibiting lipoxygenase |
| 09/28/1999 | US5958949 N-linked ureas and carbamates of piperidyl thioesters |
| 09/28/1999 | US5958947 DNA-affinic hypoxia selective cytotoxins |
| 09/28/1999 | US5958946 Applying glucuronic acid |
| 09/28/1999 | US5958945 Psychological disorders |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958941 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs |
| 09/28/1999 | US5958939 Tricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseases |
| 09/28/1999 | US5958937 Pharmaceutical formulations of poorly water soluble camptothecin analogues and NMP |
| 09/28/1999 | US5958936 For inducing antiandrogenic activity in warm-blooded animals, including humans |
| 09/28/1999 | US5958934 5-ht 2b antagonist |
| 09/28/1999 | US5958933 Having a guanidino group aliphatically linked to a xanthine group, adrenergic stimulants |
| 09/28/1999 | US5958932 Antitumor agent |
| 09/28/1999 | US5958931 Phenyl-substituted 5H-thiazolo 3,2-A!pyrimidine derivative glutamate receptor antagonists |
| 09/28/1999 | US5958929 6-aryl pyrazolo 3,4-d! pyrimidin-4-ones and compositions and methods of use thereof |